World’s Richest Person Elon Musk: ‘People Should Be Open to Psychedelics’
The Tesla and SpaceX founder, estimated to be worth nearly $200 billion, has previously hinted at using DMT.
Psychedelic Spotlight News
Why NeonMind Is Betting on Psilocybin to Curb the Global Obesity Epidemic
The psychedelic bioscience company’s top advisor tells Psychedelic Spotlight that psilocybin “affects at least the 5h2C receptor, which is dedicated towards appetite and appetite suppression.”
Wonderland Miami Brings Together Psychedelic Industry Leaders and Celebrity Advocates
Organizers of the largest psychedelic business event ever promise it’s not just a conference, but an experience.
Mind Cure Health Targeting Hypoactive Sexual Desire Disorder with MDMA
“Women’s desire issues have not been adequately addressed to date, and we believe this treatment incorporating MDMA and psychotherapy has real promise,” says CEO Kelsey Ramsden
MindMed Releases Data on TWO Clinical Trials: A Closer Look Into MMED’s Psilocybin and LSD studies
MindMed Releases Data on TWO Clinical Trials: A Closer Look Into MMED’s Psilocybin and LSD studies.
Mind Medicine (MindMed), (NASDAQ: MNMD, NEO: MMED, DE: MMQ), announced that Dr. Matthias Liechti presented data from several ongoing studies at the INSIGHT Conference in Berlin, Germany, conducted as part of MindMed’s ongoing collaboration with the UHB Liechti Lab.
STUDIES:
https://clinicaltrials.gov/ct2/show/NCT03912974?term=psilocybin+escitalopram&draw=2&rank=2
https://clinicaltrials.gov/ct2/show/NCT03604744?term=LSD+PSilocybin&draw=2&rank=1
https://mindmed.co/news/press-release/mindmed-and-liechti-lab-provide-results-from-their-psilocybin-rd-collaboration/?fbclid=IwAR2_2fUvNf-VTF36Sv6Oz-XB8PTjscqjMWMFF5CKBvKQU2yLMOI_ZP4aq18
Enjoy the episode!
Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com
Music from:
www.bensound.com
Video editing: @themyaholy
Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#mindmed #mmed #mnmdstock
Interview with Trevor Millar, Advisor, NeonMind Biosciences
In our conversation with Trevor, we have the opportunity to discuss some of the psychedelic-based treatments NeonMind is currently focused on developing to help tackle obesity. Obesity is one of the more prevalent health conditions today affecting millions of individuals worldwide. The World Health Organization has claimed that obesity has reached epidemic proportions globally with at least 2.8 million people dying each year as a result of being overweight or obese.
How Cybin Is ‘Revolutionizing’ Mental Healthcare with Novel Psychedelic Compounds
CEO Doug Drysdale explains several key factors in making psychedelic-assisted therapy accessible for the millions of people suffering around the globe.
Survey Shows American Psychologists Still Don’t Really Understand Psychedelics
Less than half of psychologists surveyed agreed that psychedelics showed promise in the treatment of serious mental health issues.
Psychedelic Business Spotlight: September 24, 2021
This week in psychedelic business news: two patents may revolutionize the medical application of psychedelic compounds; DMT and ibogaine clinical trials show promise; and stock news for psychedelic investors.
‘Nine Perfect Strangers’ Director Calls Psychedelics a ‘Salvation of Humanity’
But the psychedelic community is concerned the Hulu series is full of “misinformation” about psychedelic-assisted therapy, and think the show may be harmful to the progressive movement.
End of content
End of content